Company / Profit Margin
Nuvation Bio Inc. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-325.3%
FY2025
5-year range
-7213.8% / -325.3%
FY2024-FY2025
Trend
+95.5%
vs FY2024
Sector context
#117 of 146
Health Care
What the data says
Nuvation Bio Inc.'s profit margin of -325.3% is lower than 80% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-325.3% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 146This company -325.3% Sector average -796.3%
▼
+59.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 95.5% year-over-year.
- Currently 471.0pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -325.3% | +95.5% |
| FY2024 | -7213.8% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026